138 related articles for article (PubMed ID: 27790713)
1. Emerging roles of RAC1 in treating lung cancer patients.
Zou T; Mao X; Yin J; Li X; Chen J; Zhu T; Li Q; Zhou H; Liu Z
Clin Genet; 2017 Apr; 91(4):520-528. PubMed ID: 27790713
[TBL] [Abstract][Full Text] [Related]
2. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.
Bid HK; Roberts RD; Manchanda PK; Houghton PJ
Mol Cancer Ther; 2013 Oct; 12(10):1925-34. PubMed ID: 24072884
[TBL] [Abstract][Full Text] [Related]
3. Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.
Zou T; Yin J; Zheng W; Xiao L; Tan L; Chen J; Wang Y; Li X; Qian C; Cui J; Zhang W; Zhou H; Liu Z
Cancer Chemother Pharmacol; 2016 Aug; 78(2):249-58. PubMed ID: 27299748
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.
Chen QY; Xu LQ; Jiao DM; Yao QH; Wang YY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ
Int J Mol Med; 2011 Nov; 28(5):769-76. PubMed ID: 21837360
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
6. Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.
Vader P; van der Meel R; Symons MH; Fens MH; Pieters E; Wilschut KJ; Storm G; Jarzabek M; Gallagher WM; Schiffelers RM; Byrne AT
Angiogenesis; 2011 Dec; 14(4):457-66. PubMed ID: 21789714
[TBL] [Abstract][Full Text] [Related]
7. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Chen QY; Zheng Y; Jiao DM; Chen FY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ; Lv GY
J Nutr Biochem; 2014 Feb; 25(2):177-85. PubMed ID: 24445042
[TBL] [Abstract][Full Text] [Related]
9. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells.
Zanca C; Cozzolino F; Quintavalle C; Di Costanzo S; Ricci-Vitiani L; Santoriello M; Monti M; Pucci P; Condorelli G
J Cell Physiol; 2010 Oct; 225(1):63-72. PubMed ID: 20648624
[TBL] [Abstract][Full Text] [Related]
10. Effect of Rac1 downregulation mediated by shRNA on the biological behaviour of human cervical cancer cells.
Xu AL; Yu GQ; Kong XC; Qiu XH; Li PL
J Int Med Res; 2013 Aug; 41(4):1037-48. PubMed ID: 23760915
[TBL] [Abstract][Full Text] [Related]
11. RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.
Wu N; Ren D; Li S; Ma W; Hu S; Jin Y; Xiao S
BMC Cancer; 2018 Jan; 18(1):67. PubMed ID: 29321004
[TBL] [Abstract][Full Text] [Related]
12. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
13. Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors.
De P; Rozeboom BJ; Aske JC; Dey N
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545340
[TBL] [Abstract][Full Text] [Related]
14. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
15. Rac1 is correlated with aggressiveness and a potential therapeutic target for gastric cancer.
Ji J; Feng X; Shi M; Cai Q; Yu Y; Zhu Z; Zhang J
Int J Oncol; 2015 Mar; 46(3):1343-53. PubMed ID: 25585795
[TBL] [Abstract][Full Text] [Related]
16. RAC1 Takes the Lead in Solid Tumors.
De P; Aske JC; Dey N
Cells; 2019 Apr; 8(5):. PubMed ID: 31027363
[TBL] [Abstract][Full Text] [Related]
17. Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.
Zavarella S; Nakada M; Belverud S; Coniglio SJ; Chan A; Mittler MA; Schneider SJ; Symons M
J Neurosurg Pediatr; 2009 Aug; 4(2):97-104. PubMed ID: 19645540
[TBL] [Abstract][Full Text] [Related]
18. The Ins and Outs of Small GTPase Rac1 in the Vasculature.
Marinković G; Heemskerk N; van Buul JD; de Waard V
J Pharmacol Exp Ther; 2015 Aug; 354(2):91-102. PubMed ID: 26036474
[TBL] [Abstract][Full Text] [Related]
19. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
20. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review.
Perlikos F; Harrington KJ; Syrigos KN
Crit Rev Oncol Hematol; 2013 Jul; 87(1):1-11. PubMed ID: 23332547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
